Sargramostim: Uses, Dosage, Side Effects & Administration

Key Points About Sargramostim

Sargramostim is a medication designed to stimulate the production of white blood cells, particularly after chemotherapy or bone marrow transplants. It is commonly prescribed for conditions such as acute myeloid leukemia (AML), neutropenia, and aplastic anemia. By enhancing the immune system, Sargramostim helps lower the risk of infections. Always consult your healthcare provider before starting this medication or making any changes to your dosage.

Medication Names: Sargramostim and Leukine

US Brand Name: Leukine

Generic Name: Sargramostim

The generic name, Sargramostim, refers to the active ingredient in the medication, while Leukine is the brand name assigned by the manufacturer.

Pharmacologic Category of Sargramostim

Sargramostim belongs to the following pharmacologic categories:

1. Colony-Stimulating Factor (CSF)
2. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

Sargramostim Dosage Guidelines

The appropriate dosage of Sargramostim depends on the condition being treated. Always follow your healthcare provider’s instructions and consult them before making any changes to your treatment plan.

1. Acute Myeloid Leukemia (AML): 250 mcg/m²/day, administered intravenously or subcutaneously, starting 4 days after chemotherapy and continuing until the absolute neutrophil count (ANC) exceeds 1,500 cells/mm³ for 3 consecutive days.
2. Bone Marrow Transplant: 250 mcg/m²/day, administered intravenously, starting 2–4 hours after bone marrow infusion and continuing until ANC exceeds 1,500 cells/mm³ for 3 consecutive days.
3. Aplastic Anemia: 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
4. Neutropenia: 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
5. Chronic Myeloid Leukemia (CML): 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
6. Non-Hodgkin Lymphoma: 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
7. Myelodysplastic Syndromes: 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
8. HIV/AIDS: 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
9. Sepsis: 250 mcg/m²/day, administered subcutaneously or intravenously, until ANC improves. The duration of treatment depends on the patient’s response.
10. Chemotherapy-Induced Neutropenia: 250 mcg/m²/day, administered subcutaneously or intravenously, starting 24 hours after chemotherapy and continuing until ANC exceeds 1,500 cells/mm³ for 3 consecutive days.

Always consult your healthcare provider before adjusting your dose. If you need assistance, consider scheduling an appointment with one of our telemedicine doctors today.

Dosage Forms and Strengths of Sargramostim

1. Injection, Powder for Reconstitution: 250 mcg/vial
2. Injection, Solution: 500 mcg/mL

Administration Guidelines for Sargramostim

Sargramostim is typically administered as an injection either under the skin (subcutaneously) or directly into a vein (intravenously). Your healthcare provider will determine the most suitable method for your treatment. If you are administering the medication at home, carefully follow the instructions provided by your healthcare team. For subcutaneous injections, rotate injection sites and avoid areas that are red, swollen, or irritated.

Potential Side Effects of Sargramostim

As with any medication, Sargramostim may cause side effects. Some are mild and common, while others are rare but more serious. Contact your healthcare provider if you experience any symptoms that concern you.

Common Side Effects

1. Fever: A mild increase in body temperature is a frequent and usually temporary side effect.
2. Bone Pain: Discomfort in the bones, particularly in the hips or lower back, may occur.
3. Fatigue: Feeling tired or weak is common, especially during the early days of treatment.
4. Injection Site Reactions: Redness, swelling, or pain at the injection site may develop.

Less Common Side Effects

1. Shortness of Breath: Difficulty breathing or wheezing, particularly in individuals with pre-existing lung conditions.
2. Swelling: Fluid retention may cause swelling in the hands, feet, or ankles.
3. Rash: Skin reactions, such as rash or itching, may occur.

Serious Side Effects (Rare)

1. Allergic Reactions: Severe allergic reactions, including difficulty breathing, hives, or swelling of the face, lips, or throat, require immediate medical attention.
2. Heart Problems: In rare cases, Sargramostim may cause heart-related issues, such as a rapid heart rate or chest pain. Contact your healthcare provider immediately if you experience these symptoms.

Contraindications

A contraindication refers to a specific condition or circumstance in which a treatment or medication, such as Sargramostim, should not be used because it may cause harm. Before starting Sargramostim, it is essential to identify any conditions that could make this medication unsafe for you.

Contraindications for Sargramostim

Hypersensitivity to Sargramostim or yeast-derived products: If you have ever had an allergic reaction to Sargramostim or yeast-derived products, you should avoid this medication. Allergic reactions can range from mild symptoms, such as skin rashes, to severe, potentially life-threatening conditions like anaphylaxis.

Excessive leukemic blasts in bone marrow or peripheral blood:Sargramostim stimulates the production of white blood cells, which can worsen conditions involving an overproduction of immature white blood cells (blasts), such as certain forms of leukemia.

Fluid retention disorders: Conditions such as congestive heart failure, pulmonary edema, or pleural effusion may be aggravated by Sargramostim, potentially leading to complications like swelling or difficulty breathing.

Severe renal or hepatic dysfunction: Individuals with significant kidney or liver impairment may have difficulty metabolizing Sargramostim, increasing the risk of side effects or toxicity.

Drug-to-Drug Interactions

It is important to inform your healthcare provider about all medications you are currently taking, as Sargramostim may interact with other drugs. These interactions could increase the likelihood of side effects or reduce the effectiveness of your treatment.

Medications That May Interact with Sargramostim

Lithium (Lithobid): Lithium can enhance white blood cell production, which may amplify the effects of Sargramostim, potentially leading to an excessive increase in white blood cell counts.

Corticosteroids (Prednisone, Dexamethasone): These immune-suppressing medications may counteract the effects of Sargramostim, reducing its efficacy.

Antineoplastic agents (Chemotherapy drugs): Some chemotherapy drugs may interfere with Sargramostim‘s ability to stimulate white blood cell production. Your healthcare provider may adjust your treatment schedule to minimize potential conflicts.

Sargramostim in Pregnancy

Is it safe to take Sargramostim when pregnant?

Sargramostim is classified as a Category C drug by the FDA, meaning there are no well-controlled studies in pregnant women. While animal studies have shown adverse effects on fetal development, the potential benefits of the medication may outweigh the risks in certain situations. If you are pregnant or planning to become pregnant, it is vital to discuss the potential risks and benefits with your healthcare provider. Our telemedicine providers are also available to help you make an informed decision about your treatment options.

Sargramostim While Breastfeeding

Is it safe to take Sargramostim while breastfeeding?

It is not yet known whether Sargramostim passes into breast milk. Due to the potential risk of serious side effects in nursing infants, it is generally recommended to either discontinue breastfeeding or stop taking the medication. If you are breastfeeding, consult your healthcare provider to determine the best course of action. You can also speak with one of our telemedicine providers to explore your options and receive personalized guidance.

Estimated Cost of Sargramostim

The estimated cost of a 30-day supply of Sargramostim without insurance ranges from $2,500 to $3,500, depending on the dosage and the pharmacy. However, using a GoodRx coupon may reduce the price to approximately $2,000. Prices can vary, so it is advisable to check with your pharmacy or use a prescription discount service to find the most accurate and affordable pricing.

Possible Alternatives to Sargramostim

There are alternative treatments and lifestyle changes that may help manage your condition. Always consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss these options in detail.

Acute Myeloid Leukemia (AML)

1. Chemotherapy: Standard chemotherapy regimens are commonly used to treat AML.
2. Targeted therapy: Medications such as midostaurin (Rydapt) may be prescribed for specific genetic mutations.
3. Stem cell transplant: A bone marrow or stem cell transplant may be recommended in certain cases.

Bone Marrow Transplant

1. Immunosuppressive therapy: Drugs like cyclosporine are used to prevent transplant rejection.
2. Supportive care: Blood transfusions and antibiotics may be necessary to address complications.

Aplastic Anemia

1. Immunosuppressive therapy: Medications such as antithymocyte globulin (ATG) and cyclosporine are commonly used.
2. Blood transfusions: These may be required to manage low blood counts.

Neutropenia

1. Filgrastim (Neupogen): Another growth factor that stimulates white blood cell production.
2. Antibiotics: Used to prevent or treat infections caused by low white blood cell counts.

Chronic Myeloid Leukemia (CML)

1. Tyrosine kinase inhibitors: Medications such as imatinib (Gleevec) are standard treatments for CML.

Non-Hodgkin Lymphoma

1. Chemotherapy: Standard regimens are often used to treat this condition.
2. Targeted therapy: Drugs like rituximab (Rituxan) may be prescribed in specific cases.

Myelodysplastic Syndromes (MDS)

1. Azacitidine (Vidaza): A medication that helps improve blood counts in MDS patients.
2. Supportive care: Blood transfusions and antibiotics may be necessary.

HIV/AIDS

1. Antiretroviral therapy (ART): The standard treatment for managing HIV/AIDS.
2. Prophylactic antibiotics: Used to prevent infections in patients with low white blood cell counts.

Sepsis

1. Antibiotics: Immediate treatment with broad-spectrum antibiotics is critical.
2. Supportive care: Fluids, oxygen, and medications to stabilize blood pressure may be required.

Chemotherapy-Induced Neutropenia

1. Filgrastim (Neupogen): Another growth factor that stimulates white blood cell production.
2. Antibiotics: Used to prevent or treat infections caused by low white blood cell counts.

Recent Updates on Sargramostim Research

Recent research on Sargramostim, also marketed under the brand name Leukine, has broadened its scope to investigate potential applications beyond its currently approved uses. Scientists are particularly examining its ability to strengthen immune responses, with a focus on patients battling viral infections such as COVID-19. These studies aim to evaluate whether Sargramostim can improve lung function and alleviate severe respiratory symptoms in affected individuals.

Early findings have shown encouraging results, with some patients experiencing notable improvements in respiratory health. However, further clinical trials are necessary to validate these outcomes and to develop comprehensive Sargramostim administration guidelines. If you would like to explore more about Sargramostim’s potential benefits or determine whether this therapy might be suitable for your condition, we encourage you to schedule a telemedicine consultation with one of our knowledgeable providers today.

James Kingsley

Learn More